Literature DB >> 6427257

Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency.

E A Schriock, R H Lustig, S M Rosenthal, S L Kaplan, M M Grumbach.   

Abstract

Synthetic, amidated, 44 amino acid GH-releasing hormone ( GRH -44) was administered iv at a dose of 5 micrograms/kg to 20 patients with severe GH deficiency (GHD), 6 children and adolescents with partial GHD, and 6 non-GH deficient ( NGHD ) children and adolescents. The 17 patients with severe GHD that responded to GRH -44 had lower peak concentrations of plasma GH than the NGHD individuals (5.0 +/- 1.2 (SEM) vs. 27.2 +/- 3.5 ng/ml; P less than 0.0001). The children and adolescents with severe GHD tended to have higher peak GH responses to GRH -44 than the GHD adults (6.9 +/- 1.7 vs. 2.4 +/- 0.3 ng/ml) although the difference was not significant. The peak GH concentration was attained earlier in the GHD children and adolescents than in the GHD adults (28 +/- 4.7 vs. 69.3 +/- 13 min, P less than 0.004). There was a negative correlation between chronological age and peak plasma GH response to GRH in the children and adolescents with severe GHD (r = -0.758, P less than 0.02). Children and adolescents with partial GHD had a higher mean peak concentration of plasma GH (13. 1 +/- 1.8 ng/ml) than the children, adolescents, and adults with severe GHD (P less than 0.04), but one lower than the NGHD children and adolescents (P less than 0.05). In both severe and partial GHD the GH response to GRH was greater than that elicited by standard pharmacological tests. Serum somatomedin-C did not increase after a single pulse of GRH -44 in the 12 GHD patients studied. PRL increased minimally 30 min after 5 micrograms/kg iv GRH -44 in patients with multiple hypothalamic-pituitary hormone deficiencies but not in patients with isolated GHD or in NGHD individuals. The GH responses to GRH suggest that the majority of patients with isolated GHD as well as those with multiple hypothalamic-pituitary hormone deficiencies have deficiency of hypothalamic GRH . Lack of a GH response to a single pulse of GRH does not exclude GRH deficiency as priming of the somatotrope with multiple pulses of GRH may be necessary to rule out a hypothalamic defect in the nonresponders. The results of this study support the potential usefulness of GRH or its analogs in the diagnosis and treatment of selected patients with disorders of GH secretion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427257     DOI: 10.1210/jcem-58-6-1043

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Endocrine function and morphological findings in patients with disorders of the hypothalamo-pituitary area: a study with magnetic resonance.

Authors:  E Cacciari; S Zucchini; G Carlà; P Pirazzoli; A Cicognani; M Mandini; M Busacca; C Trevisan
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

Review 2.  Proper use of growth hormone.

Authors:  R D Milner
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

3.  Long term growth hormone (GH)-releasing hormone and biosynthetic GH therapy in GH-deficient children: comparison of therapeutic effectiveness.

Authors:  M Bozzola; I Biscaldi; M Cisternino; F Severi; A Balsamo; E Cacciari; C Pellini; G Chiumello; G L Spadoni; B Boscherini
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

Review 4.  Clonidine treatment in children with short stature.

Authors:  S Loche; A Lampis; S G Cella; V Locatelli; E E Müller; C Pintor
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

5.  Growth hormone deficiency in children: role of magnetic resonance imaging in assessing aetiopathogenesis and prognosis in idiopathic hypopituitarism.

Authors:  C Pellini; B di Natale; R De Angelis; N Bressani; G Scotti; F Triulzi; G Chiumello
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

6.  Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men.

Authors:  S M Rosenthal; J A Hulse; S L Kaplan; M M Grumbach
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

7.  Growth hormone releasing hormone (GH-RH, GRF)--an important new clinical tool.

Authors:  Z Laron; B Bauman
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

8.  Growth hormone response to hpGRF-40 in different forms of growth retardation and endocrine-metabolic diseases.

Authors:  C Pintor; S Loche; R Puggioni; S G Cella; V Locatelli; F Villa; R Corda; E E Müller
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

9.  Growth hormone releasing hormone.

Authors:  M O Savage; G M Besser
Journal:  Arch Dis Child       Date:  1985-05       Impact factor: 3.791

10.  Growth hormone-releasing hormone: a clinical perspective.

Authors:  R Khardori; P S Menon
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.